Real time insider trading transaction history:
- Insiders are prohibited from making short-swing profits by trading their shares within 6 months of the registration or acquiring the shares.
"Insiders might sell their shares for any number of reasons, but they buy them for only one: they think the price will rise"
- Peter Lynch
What is insider trading>>
- Peter Lynch
What is insider trading>>
Common stock purchase or sale:
| Transaction Date | Reported DateTime | Company | Symbol | Insider Relationship | Shares Traded | Average Price | Total Amount | Shares Owned | Filing |
| 2021-03-23 Sale | 2021-03-25 5:39 pm | CRISPR Therapeutics AG | CRSP | Klein Lawrence Otto COO | 100,000 | $128.05 | $12,805,240 | 122,716 (Direct) | View |
| 2021-01-15 Sale | 2021-01-20 6:07 pm | CRISPR Therapeutics AG | CRSP | Klein Lawrence Otto COO | 25,000 | $215.2 | $5,379,940 | 34,666 (Direct) | View |
| 2020-06-24 Sale | 2020-06-26 4:33 pm | CRISPR Therapeutics AG | CRSP | Klein Lawrence Otto COO | 70,000 | $75.88 | $5,311,564 | 42,244 (Direct) | View |
| 2020-05-11 Sale | 2020-05-13 4:38 pm | CRISPR Therapeutics AG | CRSP | Klein Lawrence Otto COO | 25,000 | $60.4 | $1,509,971 | 58,666 (Direct) | View |
| 2019-07-10 Sale | 2019-07-12 4:13 pm | CRISPR Therapeutics AG | CRSP | Klein Lawrence Otto Chief Business Officer | 20,000 | $50.02 | $1,000,353 | 155,753 (Direct) | View |
Stock options: Exercise, Award, Grant, Conversion
| Transaction Date | Reported DateTime | Exercisable Expiration | Company | Symnbol | Insider Relationship | Shares Traded | Conversion Price | Shares Owned | Filing |
| 2022-10-12 Option Award | 2022-10-13 8:07 pm | N/A N/A | Jasper Therapeutics Inc. | JSPR | Klein Lawrence Otto Director | 24,500 | $0 | 24,500 (Direct) | View |
| 2022-08-16 Option Award | 2022-08-18 5:36 pm | N/A N/A | CRISPR Therapeutics AG | CRSP | Klein Lawrence Otto COO | 12,500 | $0 | 12,500 (Direct) | View |
| 2022-07-05 Option Award | 2022-07-06 6:20 pm | N/A 2030-07-30 | Dyne Therapeutics Inc. | DYN | Klein Lawrence Otto Director | 7,222 | $0 | 7,222 (Direct) | View |
| 2022-06-03 Option Award | 2022-06-06 4:07 pm | N/A 2032-06-02 | Dyne Therapeutics Inc. | DYN | Klein Lawrence Otto Director | 19,596 | $0 | 19,596 (Direct) | View |
| 2022-03-21 Option Award | 2022-03-23 6:05 pm | N/A 2032-03-21 | Jasper Therapeutics Inc. | JSPR | Klein Lawrence Otto Director | 78,045 | $0 | 78,045 (Direct) | View |
| 2022-03-10 Exercise | 2022-03-14 6:03 pm | N/A N/A | CRISPR Therapeutics AG | CRSP | Klein Lawrence Otto COO | 7,584 | $0 | 40,380 (Direct) | View |
| 2022-03-10 Tax Withholding | 2022-03-14 6:03 pm | N/A N/A | CRISPR Therapeutics AG | CRSP | Klein Lawrence Otto COO | 1,883 | $62.56 | 40,380 (Direct) | View |
| 2022-03-10 Tax Withholding | 2022-03-14 6:03 pm | N/A N/A | CRISPR Therapeutics AG | CRSP | Klein Lawrence Otto COO | 1,229 | $61.08 | 40,380 (Direct) | View |
| 2022-02-18 Option Award | 2022-02-22 5:41 pm | N/A 2032-02-18 | CRISPR Therapeutics AG | CRSP | Klein Lawrence Otto COO | 66,600 | $0 | 66,600 (Direct) | View |
| 2021-12-03 Exercise | 2021-12-07 8:00 pm | N/A N/A | CRISPR Therapeutics AG | CRSP | Klein Lawrence Otto COO | 26,667 | $0 | 35,658 (Direct) | View |
| 2021-12-03 Tax Withholding | 2021-12-07 8:00 pm | N/A N/A | CRISPR Therapeutics AG | CRSP | Klein Lawrence Otto COO | 11,185 | $69.17 | 35,658 (Direct) | View |
| 2021-10-15 Option Award | 2021-10-18 8:00 pm | N/A 2031-10-15 | CRISPR Therapeutics AG | CRSP | Klein Lawrence Otto COO | 13,800 | $0 | 13,800 (Direct) | View |
| 2021-09-10 Exercise | 2021-09-14 9:44 pm | N/A N/A | CRISPR Therapeutics AG | CRSP | Klein Lawrence Otto COO | 10,000 | $0 | 6,843 (Direct) | View |
| 2021-09-10 Tax Withholding | 2021-09-14 9:44 pm | N/A N/A | CRISPR Therapeutics AG | CRSP | Klein Lawrence Otto COO | 10,000 | $0 | 6,843 (Direct) | View |
| 2021-09-10 Tax Withholding | 2021-09-14 9:44 pm | N/A N/A | CRISPR Therapeutics AG | CRSP | Klein Lawrence Otto COO | 4,207 | $117.86 | 6,843 (Direct) | View |
| 2021-05-26 Option Award | 2021-05-27 8:38 pm | N/A 2031-05-25 | Dyne Therapeutics Inc. | DYN | Klein Lawrence Otto Director | 19,596 | $0 | 19,596 (Direct) | View |
| 2021-03-23 Exercise | 2021-03-25 5:39 pm | N/A 2027-06-14 | CRISPR Therapeutics AG | CRSP | Klein Lawrence Otto COO | 88,000 | $0 | 122,716 (Direct) | View |
| 2021-03-23 Exercise | 2021-03-25 5:39 pm | N/A N/A | CRISPR Therapeutics AG | CRSP | Klein Lawrence Otto COO | 22,000 | $51.49 | 122,716 (Direct) | View |
| 2021-03-23 Exercise | 2021-03-25 5:39 pm | N/A N/A | CRISPR Therapeutics AG | CRSP | Klein Lawrence Otto COO | 10,000 | $29.87 | 122,716 (Direct) | View |
| 2021-03-23 Exercise | 2021-03-25 5:39 pm | N/A N/A | CRISPR Therapeutics AG | CRSP | Klein Lawrence Otto COO | 20,000 | $40.87 | 122,716 (Direct) | View |
| 2021-03-23 Exercise | 2021-03-25 5:39 pm | N/A N/A | CRISPR Therapeutics AG | CRSP | Klein Lawrence Otto COO | 12,000 | $14.43 | 122,716 (Direct) | View |
| 2021-03-23 Exercise | 2021-03-25 5:39 pm | N/A N/A | CRISPR Therapeutics AG | CRSP | Klein Lawrence Otto COO | 12,000 | $17.66 | 122,716 (Direct) | View |
| 2021-03-23 Exercise | 2021-03-25 5:39 pm | N/A N/A | CRISPR Therapeutics AG | CRSP | Klein Lawrence Otto COO | 12,000 | $44.67 | 122,716 (Direct) | View |
| 2021-03-10 Exercise | 2021-03-12 5:47 pm | N/A N/A | CRISPR Therapeutics AG | CRSP | Klein Lawrence Otto COO | 4,583 | $0 | 58,384 (Direct) | View |
| 2021-03-10 Option Award | 2021-03-12 5:47 pm | N/A 2031-03-11 | CRISPR Therapeutics AG | CRSP | Klein Lawrence Otto COO | 45,334 | $0 | 58,384 (Direct) | View |
| 2021-03-10 Tax Withholding | 2021-03-12 5:47 pm | N/A N/A | CRISPR Therapeutics AG | CRSP | Klein Lawrence Otto COO | 2,141 | $124.15 | 58,384 (Direct) | View |
| 2021-01-15(A) Exercise | 2021-03-12 5:37 pm | N/A N/A | CRISPR Therapeutics AG | CRSP | Klein Lawrence Otto COO | 16,334 | $14.43 | 37,550 (Direct) | View |
| 2021-01-15 Exercise | 2021-01-20 6:07 pm | N/A 2026-07-14 | CRISPR Therapeutics AG | CRSP | Klein Lawrence Otto COO | 25,000 | $0 | 34,666 (Direct) | View |
| 2021-01-15 Exercise | 2021-01-20 6:07 pm | N/A N/A | CRISPR Therapeutics AG | CRSP | Klein Lawrence Otto COO | 8,666 | $12.57 | 34,666 (Direct) | View |
| 2021-01-15 Exercise | 2021-01-20 6:07 pm | N/A N/A | CRISPR Therapeutics AG | CRSP | Klein Lawrence Otto COO | 16,344 | $14.43 | 34,666 (Direct) | View |
| 2021-01-02 Tax Withholding | 2021-01-04 4:12 pm | N/A N/A | CRISPR Therapeutics AG | CRSP | Klein Lawrence Otto COO | 9,392 | $153.11 | 10,608 (Direct) | View |
| 2020-10-05 Option Award | 2020-10-06 5:38 pm | N/A 2030-10-05 | CRISPR Therapeutics AG | CRSP | Klein Lawrence Otto COO | 16,666 | $0 | 16,666 (Direct) | View |
| 2020-07-31 Option Award | 2020-09-23 7:04 pm | N/A 2030-07-30 | Dyne Therapeutics Inc. | DYN | Klein Lawrence Otto Director | 25,600 | $0 | 71,899 (Direct) | View |
| 2020-07-31 Conversion | 2020-09-23 7:04 pm | N/A N/A | Dyne Therapeutics Inc. | DYN | Klein Lawrence Otto Director | 46,299 | $0 | 71,899 (Direct) | View |
| 2020-09-16 Ownership | 2020-09-16 8:43 pm | N/A 2029-09-05 | Dyne Therapeutics Inc. | DYN | Klein Lawrence Otto Director | 0 | $0 | 69,133 (Direct) | View |
| 2020-06-24 Exercise | 2020-06-26 4:33 pm | N/A 2026-03-01 | CRISPR Therapeutics AG | CRSP | Klein Lawrence Otto COO | 70,000 | $0 | 42,244 (Direct) | View |
| 2020-06-24 Exercise | 2020-06-26 4:33 pm | N/A N/A | CRISPR Therapeutics AG | CRSP | Klein Lawrence Otto COO | 31,334 | $12.57 | 42,244 (Direct) | View |
| 2020-06-24 Exercise | 2020-06-26 4:33 pm | N/A N/A | CRISPR Therapeutics AG | CRSP | Klein Lawrence Otto COO | 38,666 | $5.86 | 42,244 (Direct) | View |
| 2020-05-11 Exercise | 2020-05-13 4:38 pm | N/A 2026-03-01 | CRISPR Therapeutics AG | CRSP | Klein Lawrence Otto COO | 25,000 | $0 | 58,666 (Direct) | View |
| 2020-05-11 Exercise | 2020-05-13 4:38 pm | N/A N/A | CRISPR Therapeutics AG | CRSP | Klein Lawrence Otto COO | 25,000 | $5.86 | 58,666 (Direct) | View |
| 2020-03-10 Option Award | 2020-03-12 4:10 pm | N/A 2030-03-10 | CRISPR Therapeutics AG | CRSP | Klein Lawrence Otto COO | 68,750 | $0 | 68,750 (Direct) | View |
| 2019-12-03 Option Award | 2019-12-05 4:05 pm | N/A N/A | CRISPR Therapeutics AG | CRSP | Klein Lawrence Otto Chief Business Officer | 40,000 | $0 | 40,000 (Direct) | View |
| 2019-09-10 Option Award | 2019-09-12 4:32 pm | N/A N/A | CRISPR Therapeutics AG | CRSP | Klein Lawrence Otto Chief Business Officer | 10,000 | $0 | 30,000 (Direct) | View |
| 2019-07-10 Exercise | 2019-07-12 4:13 pm | N/A 2026-03-01 | CRISPR Therapeutics AG | CRSP | Klein Lawrence Otto Chief Business Officer | 20,000 | $0 | 155,753 (Direct) | View |
| 2019-07-10 Exercise | 2019-07-12 4:13 pm | N/A N/A | CRISPR Therapeutics AG | CRSP | Klein Lawrence Otto Chief Business Officer | 20,000 | $5.86 | 155,753 (Direct) | View |
| 2019-03-05 Option Award | 2019-03-07 4:17 pm | N/A 2029-03-05 | CRISPR Therapeutics AG | CRSP | Klein Lawrence Otto Chief Business Officer | 45,000 | $0 | 45,000 (Direct) | View |
| 2019-01-02 Option Award | 2019-01-03 4:32 pm | N/A 2029-01-01 | CRISPR Therapeutics AG | CRSP | Klein Lawrence Otto Chief Business Officer | 20,000 | $0 | 40,000 (Direct) | View |
| 2019-01-02 Option Award | 2019-01-03 4:32 pm | N/A N/A | CRISPR Therapeutics AG | CRSP | Klein Lawrence Otto Chief Business Officer | 20,000 | $29.87 | 40,000 (Direct) | View |
| 2019-01-02 Ownership | 2019-01-03 4:22 pm | N/A 2026-03-01 | CRISPR Therapeutics AG | CRSP | Klein Lawrence Otto Chief Business Officer | 0 | $0 | 229,666 (Direct) | View |